Yes, our primary validation used bone marrow and umbilical cord-derived MSCs, but clients have also successfully preserved amniotic epithelial stem cells and dental pulp stem cells with comparable outcomes.
Yes, our primary validation used bone marrow and umbilical cord-derived MSCs, but clients have also successfully preserved amniotic epithelial stem cells and dental pulp stem cells with comparable outcomes.
While efficiency varies slightly by cell source and donor, our cryopreservation protocol consistently achieves higher viability than competitors' solutions.
Cellstore Stem Cell Cryopreservation Media.
We've confirmed viability after 12+ months in cryostorage, with no observed degradation.
In theory, yes. Our ice-control technology prevents long-term cryodamage, but real-world validation beyond 1-2 years remains ongoing.
No. It's serum-free, xeno-free, and relies on pharmacopeia-grade salts + proprietary crystal inhibitors—no animal proteins or DMSO.
GMP-compliant manufacturing, coupled with stringent endotoxin/pyrogen testing, guarantees compliance for therapeutic applications.
For more information about CellStore Biotechnology or our products, feel free to contact us.
- Partnering with us?
- Want to become our distributor?
- Some feedback that you have?